Gago-Veiga, AB
Huhn, J-I
Latysheva, N
Vieira Campos, A
Torres-Ferrus, M
Alpuente Ruiz, A
Sacco, S
Frattale, I
Ornello, R
Ruscheweyh, R
Marques, IB
Gryglas-Dworak, A
Stark, C
Gallardo, VJ
Pozo-Rosich, P
Article History
Received: 4 February 2021
Accepted: 12 May 2021
First Online: 24 May 2021
Declarations
:
: This study was approved by Hospital de la Princesa´s Ethics Committee (register number: 3477). Patient data were anonymised for data analysis.
: All authors gave their consent for publication.
: Gago-Veiga AB has received honoraria as a consultant and speaker for: AbbVie-Allergan, Chiesi, Exeltis, Novartis, Eli Lilly and Teva.Huhn J-I has received honaria as speaker or travel grants for: AbbVie-Allergan, Novartis, Teva, Eli-Lilly and md-hoizonte.Latysheva N has received honoraria as a consultant and speaker for: AbbVie-Allergan and Novartis.Torres-Ferrus M has received honoraria as consultant or speaker for Allergan-Abbvie, Almirall, Chiesi, Eli Lilly, Novartis and Teva.Alpuente A has received honoraria as speaker for Allergan-Abbvie, Eli Lilly and eductation for Chiesi, Novartis and Teva.Sacco S has received honoraria as a consultant and speaker for: Abbot, Allergan-Abbvie, AstraZeneca, Eli Lilly, Novartis and Teva. Her research group has received research grants from Allergan-Abbvie and Novartis and has received funding for clinical trials from Allergan-Abbvie, Novartis and Teva. She is a member of the Council of the European Headache Society and co-chair of the guideline board of the European Stroke Organization. She is the Specialty Chief Editor in Headache Medicine and Facial Pain in Frontiers in Neurology, associate editor for The Journal of Headache and Pain and for Stroke in Frontiers in Neurology, assistant editor for Stroke and member of the editorial board of Neurological Sciences, International Journal of Stroke, European Stroke Journal.Ornello R has received personal fees from Novartis and Ei Lilly, funding for publication fees from Allergan and Novartis, and travel grants from Novartis and Teva.Ruscheweyh R has received honoraria for talks and/or advisory boards from Allergan, Hormosan, Lilly, Novartis and Teva.Marques IB has received honoraria as speaker and/or advisory board for: AbbVie-Allergan, Sanofi and Novartis.Gryglas-Dworak A. has received honoraria as a consultant or speaker for AbbVie-Allergan and Novartis.Pozo-Rosich P has received honoraria as a consultant and speaker for: Allergan-Abbvie, Almirall, Amgen, Biohaven, Chiesi, Eli Lilly, Medscape, Neurodiem, Novartis and Teva. Her research group has received research grants from Allergan, and has received funding for clinical trials from Alder, Allergan-Abbvie, Electrocore, Eli Lilly, Novartis and Teva. She is a trustee member of the board of the International Headache Society, member of the Council of the European Headache Society. She is in the editorial board of Revista de Neurologia, associate editor for Cephalalgia, Headache, Neurologia, Frontiers of Neurology and The Journal of Headache and Pain. She is a member of the Clinical Trials Guidelines Committee of the International Headache Society. She has edited the Guidelines for the Diagnosis and Treatment of Headache of the Spanish Neurological Society. She is the founder ofExternalRef removed. Pozo-Rosich P does not own stocks from any pharmaceutical company.Vieira-Campos A, Frattale I, Stark C and Gallardo VJ report no disclosures